Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024

Rhea-AI Summary

Moderna (NASDAQ:MRNA) announced it will report its second quarter 2024 financial results on Thursday, August 1, 2024, at 8:00 a.m. ET. The company will host a live conference call and webcast to discuss the results and provide a corporate update. The webcast will be accessible via the Investors section of Moderna's website and an archived version will be available approximately two hours after the event, remaining online for one year.

Moderna is a leader in mRNA medicine, known for developing one of the earliest and most effective COVID-19 vaccines. The company focuses on creating therapeutics and vaccines for various conditions, including infectious diseases, immuno-oncology, rare diseases, and autoimmune diseases. For more information, visit modernatx.com.

CAMBRIDGE, MA / ACCESSWIRE / July 10, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 1, 2024 to report its second quarter 2024 financial results, and provide a corporate update.

A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.

• Webcast: https://investors.modernatx.com

The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on accesswire.com

FAQ

When will Moderna report its second quarter 2024 financial results?

Moderna will report its second quarter 2024 financial results on Thursday, August 1, 2024, at 8:00 a.m. ET.

How can I access the live webcast for Moderna's financial results announcement?

The live webcast will be available under 'Events and Presentations' in the Investors section of Moderna's website.

Will there be an archived version of Moderna's second quarter 2024 financial results webcast?

Yes, an archived version will be available on Moderna's website approximately two hours after the conference call and will remain online for one year.

What is Moderna known for in the field of mRNA medicine?

Moderna is known for developing one of the earliest and most effective COVID-19 vaccines and focuses on creating therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, and autoimmune diseases.

Where can I find more information about Moderna's second quarter 2024 financial results?

More information can be found on Moderna's official website under the Investors section.